The Role of Toll-Like Receptors in Breast Cancer

Authors

  • Davoodi, Homa Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Nokhandani, Negin Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Abstract:

Breast cancer is highly prevalent worldwide. Treatment of this disease is a major global public health problem; therefore, numerous studies have explored new molecular profile helping for breast cancer therapy. Different risk factors are attributed to breast cancer; however, chronic inflammation and immune regulation are highly essential. Various molecules impact this context, including toll-like receptors (TLRs), which are mainly expressed on the membrane of different immune cells and trigger pro-inflammatory responses. Of note, expressing these receptors, as well as inhibiting their functions lead to different and remarkable results in patients with breast cancer. More specifically, TLRs can induce the apoptosis of cancerous cells, expression of adhesion molecules, metastasis, and cytokine profile change. Therefore, evaluating new therapies and various factors, including demographic characteristics, nutrition, colonized microbial flora, and immune regulatory molecules in breast cancer patients is essential. Such information helps to improve our understanding of this disease and assists scientists to find effective therapies in the future. The content of this article is a review of 128 articles, published in prestigious international journals. Search in Google Scholar, PubMed, Scopus, and Science Direct were conducted using keyword combinations of “Breast cancer and Toll-like receptor”. This review article is an overview of the role of TLRs in the treatment and progression of breast cancer. According to various research studies, TLRs can significantly affect the progression, metastasis, and treatment of breast cancer.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

the role of toll-like receptors in pain control

the toll like (family of receptors tlr) are expressed primarily by immune cells and are known to be part of innate immune system. in the past decade involvement of tlrs in several physiologic and pathologic pathways has been proved. pain transmission via glial activation is one of such interesting fields. both pathological pain states and treatment have also been shown to be related to tlr-rela...

full text

Toll-like receptors and breast cancer

Toll-like receptors (TLRs) are key receptors in innate immunity and inflammation and are expressed not only in innate immune cells but also in different cancer cells. Increasing evidences demonstrate that TLRs play an important role in the initiation and progression of cancer and metabolism. Currently we have limited therapeutic options to treat patients with advanced non-resectable, recurrent ...

full text

P-184: The Role of Cell Surface Toll Like Receptors in Endometriosis

Background: Toll like receptors (TLRs) are a major family of innate immune systems which recognize specific pathogen associated molecular patterns (PAMPS)in bacterial, fungi, virus and parasites. Human TLRs comprise a large family of 10 different type proteins that are expressed on various immune cells. Among these receptors, TLR1, 2, 4, 5, 6 and 10 were expressed on the cell surface. TLR2 form...

full text

The role of Toll-like receptors in ovarian cancer.

Ovarian cancer (OC) is the leading cause of death in gynecological malignancies in western countries. Chemoresistance represents a major issue and a better understanding of the interactions that take place within the tumor microenvironment is needed, such as the connection between inflammation and cancer. Toll like receptors (TLRs) are part of the basic mechanisms that are involved in the activ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 23  issue 3

pages  262- 277

publication date 2019-08

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023